Figure 5 | Scientific Reports

Figure 5

From: MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway

Figure 5

Visualization of comprehensive pharmacological results of differentially expressed genes. (a) Protein–protein interaction of potential target proteins. (b) GO analysis of differentially expressed genes (p < 0.05). (c) The top 10 KEGG pathways for potential targets (p < 0.05). (d) Prognostic value analysis of PGK1 and PIK3CA in GEPIA. (e) MAT docked with molecules of PGK1. (f) NG52 docked with molecules of PGK1. (g) MAT docked with molecules of PIK3CA. The blue cartoon model represents the receptor, the green bat model represents the ligand, and the red bat model represents the key residue binding to ASN35.

Back to article page